Stocks · Health care · Biological Products, (No Diagnostic Substances)

Editas Medicine, Inc.

EDIT Clue Score47
United States Fiscal year ends December CIK 0001650664 Results filed 5 Aug 2026

What the insiders did No buying or selling

By person

5 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Gilmore Neil O'Neill
CEO
—
—
—
243,189
$738.61K
−22.5%
Baisong Mei
EVP, Chief Medical Officer
—
—
—
133,354
$405.02K
−0.4%
Erick Lucera
EVP, Chief Financial Officer
—
—
—
112,720
$342.35K
−3.5%
Linda Burkly
EVP, Chief Scientific Officer
—
—
—
61,660
$187.27K
−21.9%
Amy Parison
SVP, Chief Financial Officer
—
—
—
13,839
$42.03K
−22.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.